Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Liquidia Corp (LQDA)

Liquidia Corp (LQDA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Insider Sale: Chief Commercial Officer of $LQDA (LQDA) Sells 546 Shares

Scott Moomaw, the Chief Commercial Officer of $LQDA ($LQDA), sold 546 shares of the company on 12-02-2024. We received data on the trade from a recent SEC filing. This was a sale of approximately 0.4%...

LQDA : 11.10 (+4.82%)
Insider Sale: General Counsel of $LQDA (LQDA) Sells 1,063 Shares

Russell Schundler, the General Counsel of $LQDA ($LQDA), sold 1,063 shares of the company on 12-02-2024. We received data on the trade from a recent SEC filing. This was a sale of approximately 0.2% of...

LQDA : 11.10 (+4.82%)
Liquidia Corporation Reports Third Quarter 2024 Financial Results and Provides Corporate Update

LQDA : 11.10 (+4.82%)
Liquidia to Present at the Stifel 2024 Healthcare Conference

LQDA : 11.10 (+4.82%)
Liquidia Corporation to Report Third Quarter 2024 Financial Results on November 13, 2024

LQDA : 11.10 (+4.82%)
Liquidia Corporation to Report Third Quarter 2024 Financial Results on November 11, 2024

LQDA : 11.10 (+4.82%)
United States Supreme Court Declines to Review Rulings that Invalidate United Therapeutics’ Patent

LQDA : 11.10 (+4.82%)
ANAVASI DIAGNOSTICS ANNOUNCES NEWLY ELECTED OUTSIDE BOARD OF DIRECTORS

/PRNewswire/ -- Anavasi Diagnostics ('Anavasi'), an NIH/RADx medical technology company focused on the development of novel molecular diagnostic testing,...

LQDA : 11.10 (+4.82%)
CYAN : 0.3005 (-24.88%)
Why Liquidia Stock Rocketed Nearly 21% Higher Today

Investors were obviously cheered by a round of insider buying.

LQDA : 11.10 (+4.82%)
UTHR : 359.58 (-0.16%)
Why Liquidia Shares Rose 18.4% on Monday

Optimism by the company regarding a patent ruling is encouraging investors.

LQDA : 11.10 (+4.82%)
UTHR : 359.58 (-0.16%)

Barchart Exclusives

Oracle Stock Is Off Its Highs and Could Be Cheap Here
Oracle Corp. produced higher revenue in Q2 but lower free cash flow and FCF margins. However, ORCL stock is now off its highs and could be undervalued here. Shorting out-of-the-money puts is one way to play it. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar